Superhumn Raises $4.4m Series A

Superhumn, Inc. announced the close of its $4.4 million Series A financing round. The round included Arben Ventures (Stanford Healthcare Innovation Labs partner, two former Goldman Sachs executives with 25-year careers at the firm, and a select group of private investors from the private equity and digital assets sector.

The company also announced that John Salley — four-time NBA champion, entrepreneur, and one of the most recognized advocates for plant-based living in professional sports — has joined Superhumn as Chief Visionary Officer.

A Massive, Underserved Market

The global plant-based protein market is valued at over $20 billion in 2025 and projected to exceed $46 billion by 2035, growing at a compound annual rate of approximately 8.5%. The widely reported "decline" in plant-based is almost entirely a US retail phenomenon — US retail sales of plant-based meat fell 10% in units in 2025 while the global market continues to grow double digits, with Asia-Pacific and Europe leading expansion. Despite high-profile failures in the retail and DTC segments, demand continues to accelerate across foodservice, CPG, industrial ingredients, and international markets. 

Commercial Traction

Superhumn has secured multimillion-dollar signed letters of intent from Fortune 500 foodservice operators, with additional contracts in late-stage negotiation across international institutional buyers. The company’s pipeline reflects strong demand from operators seeking plant-based proteins that meet the price, taste, and volume requirements of institutional kitchens.

Three Breakthroughs the Industry Has Never Delivered Simultaneously

Superhumn has reverse engineered meat at the molecular level to achieve what no other plant-based company has achieved at once: taste parity, price parity, and a clean label. The company’s products are formulated using mushroom and hemp protein with no artificial additives, binders, methylcellulose, or soy isolates — controversial ingredients commonly found in competing products. Superhumn eliminates the price premium that has historically limited mainstream adoption of plant-based alternatives.

Use of Proceeds

Proceeds from the round will fund manufacturing scale-up across multiple facilities, expansion of the company’s sales team and go-to-market infrastructure, and international expansion.